Literature DB >> 3889656

Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells.

M Schwab, G Ramsay, K Alitalo, H E Varmus, J M Bishop, T Martinsson, G Levan, A Levan.   

Abstract

SEWA tumour cells are derived from an osteosarcoma induced in an A.SW mouse by infection with polyoma virus. Cytogenetic analyses have revealed three different characteristic chromosomal abnormalities diagnostic for the presence of amplified genes: 'double minutes' (DMs), homogeneously staining chromosomal regions (HSRs) and C-bandless chromosomes (CMs; for review see ref. 2). DMs may undergo fluctuation in number depending on the conditions in which the cells grow. Their number usually increases after injection of cells into a mouse and often is reduced to undetectable levels when the cells are explanted back into tissue culture; when the cells are re-introduced into the mouse, they again acquire multiple DMs. We show here that cells of SEWA lines carrying DMs, HSRs or CMs contain amplified copies of the proto-oncogene c-myc and enhanced levels of c-myc messenger RNA and c-myc protein. DMs or CMs are the sites of c-myc amplification in two different SEWA lines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889656     DOI: 10.1038/315345a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Localization of viral transforming sequences within marker chromosomes associated with tumor formation and progression in a murine fibrosarcoma.

Authors:  L Doneda; P Custode; C de G Morghen; L Larizza
Journal:  Cytotechnology       Date:  1987-10       Impact factor: 2.058

Review 2.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

3.  The PVT gene frequently amplifies with MYC in tumor cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms.

Authors:  J C Reed; J D Alpers; P C Nowell
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

5.  Inducible overproduction of the mouse c-myc protein in mammalian cells.

Authors:  F M Wurm; K A Gwinn; R E Kingston
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 6.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

7.  Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences.

Authors:  J D Hunt; M Valentine; A Tereba
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

8.  Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.

Authors:  J Y Ljubimova; L M Petrovic; N Arkadopoulos; P Blanc; S A Geller; A A Demetriou
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

9.  Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S.

Authors:  D Cherif; C Lavialle; N Modjtahedi; M Le Coniat; R Berger; O Brison
Journal:  Chromosoma       Date:  1989-01       Impact factor: 4.316

10.  Analysis of gene amplification in human tumor cell lines.

Authors:  M Fukumoto; D H Shevrin; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.